Clinical Trials Logo

Clinical Trial Summary

Joint pain is reported by about 1/3 of U.S. adults, and increases with age reaching 50% prevalence among the elderly [1]. Joint pain is associated with substantial activity limitation, work disability, sleep disturbance, negative mood (e.g., depression, anxiety, stress), and reduced quality of life (2, 3). Conventional treatment of joint pain with non-steroidal anti-inflammatory drugs (NSAIDs) and other analgesics is associated with gastrointestinal and cardiovascular side effects, and other adverse health effects [4]. Use of alternative supplements is reported by about 50% of people with knee osteoarthritis, and well-designed human trials are needed to identify effective analgesic alternatives [5]. The most widely used and studied joint pain supplements include those related to chondroprotection such as glucosamine, chondroitin, collagen hydrolysates, and hyaluronic acid [6-9]. Further research is needed examining the effects of other herbal supplementation on joint pain and overall health. Preliminary research reveals Q-ActinTM supplementation may be an effective intervention to reduce OA-related pain compared with standard treatments. Q-ActinTM is a cucumber extract with the anti-inflammatory iminosugar idoBR1 standardised to over 1%. Study Purpose To conduct a 8 week randomized double-blind placebo-controlled trial to examine the effectiveness of daily use of Q-ActinTM supplementation compared to placebo on joint pain, stiffness, function, mood, sleep, daytime activity, and health-related quality of life in adults with a history (>3 months) of mild to moderate joint pain.


Clinical Trial Description

To conduct a 8 week randomized double-blind placebo-controlled trial to examine the effectiveness of daily use of Q-ActinTM supplementation compared to placebo on joint pain, stiffness, function, mood, sleep, daytime activity, and health-related quality of life in adults with a history (>3 months) of mild to moderate joint pain. Assessments will be completed at Day 0 (Baseline), Week 2, Week 4, and Week 8. The primary outcome will be on joint pain, stiffness, and function (as assessed by the WOMAC). Secondary outcomes will be sleep quality, physical activity, daytime fatigue, mood, anxiety, perceived stress, pain severity, tolerance and limitations, and health-related quality of life. Adults (N = 80) will be randomized to one of the following conditions: - Q-ActinTM (n = 40) - Placebo control (n = 40) ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06246383
Study type Interventional
Source Jacksonville University
Contact
Status Not yet recruiting
Phase N/A
Start date February 2024
Completion date July 2024

See also
  Status Clinical Trial Phase
Completed NCT05052112 - Cross-Over Study to Evaluate the Efficacy of E-PR-01 on Activity Induced Joint Pain N/A
Recruiting NCT04285112 - SPRINT: Signature for Pain Recovery IN Teens
Completed NCT04506411 - Turmeric Efficacy for Mobility and Joint Function N/A
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Completed NCT04408560 - Evaluation of the Efficacy of a Homeopathic Protocol in Patients With Non-metastatic Breast Cancer N/A
Completed NCT04150211 - Effects of Exten(d) Supplementation on Training Ability in Recreational Runners Phase 2
Completed NCT03209895 - Study to Evaluate the Safety and Efficacy of a Proprietary "Joint Health" Dietary Supplement in Subjects With Joint and Connective Tissue Pain N/A
Withdrawn NCT01612728 - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Phase 2
Completed NCT00691678 - Glucosamine and Chondroitin for Aromatase Inhibitor Induced Joint Symptoms in Women With Breast Cancer Phase 2
Recruiting NCT05212259 - Clinical Study to Evaluate the Effect of Different Doses of UC-II® Supplementation on the Range of Motion & Joint Discomfort in Healthy Subjects N/A
Recruiting NCT04182659 - Long Term Efficacy of Neuronavigation Guided rTMS in Alleviating Gulf War Illness Related Headaches and Pain Symptoms N/A
Terminated NCT04712019 - Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA N/A
Recruiting NCT06074744 - Subsartorial Nerve Block and Femoral Nerve Block in Total Knee Arthroplasty N/A
Recruiting NCT00325845 - Synvisc Injections for Lumbar Facet Joint Pain Phase 3
Terminated NCT04872556 - Evaluation of the Effect of Laser Acupuncture on Taxane Acute Pain Syndrome Patients N/A
Active, not recruiting NCT03865992 - Curcumin in Reducing Joint Pain in Breast Cancer Survivors With Aromatase Inhibitor-Induced Joint Disease N/A
Recruiting NCT05282992 - NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort N/A
Recruiting NCT04994249 - Diagnostic and Prognostic Biomarkers for High-impact Chronic Pain: Development and Validation
Completed NCT01509079 - Vitamin D3 Effects on Musculoskeletal Symptoms With Use of Aromatase Inhibitors Phase 2
Completed NCT04764110 - Short-term Impact of Cyplexinol® on Self-reported Joint Pain N/A